Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 425

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

Open access
Lederman, M. M., Connick, E., Landay, A., Kuritzkes, D. R., Spritzler, J., St. Clair, M., Kotzin, B. L., Fox, L., Heath Chiozzi, M., Leonard, J. M., Rousseau, F., Wade, M., Roe, J. D., Martinez, A., Kessler, H.·1998·Journal of Infectious Diseases

Abstract

Human immunodeficiency virus (HIV)-1 infection is associated with progressive cell-mediated immune deficiency and abnormal immune activation. Although highly active antiretroviral therapy regimens can increase circulating CD4 T lymphocyte counts and decrease the risk of opportunistic complications, the effects of these treatments on immune reconstitution are not well understood. In 44 persons with moderately advanced HIV-1 infection, after 12 weeks of treatment with zidovudine, lamivudine, and ritonavir, plasma HIV-1 RNA fell a median of 2.3 logs (P < .0001). Circulating numbers of naive and memory CD4 T lymphocytes (P < .001), naive CD8 T lymphocytes (P < .004), and B lymphocytes (P < .001) increased. Improved lymphocyte proliferation to certain antigens and a tendency to improvement in delayed-type hypersensitivity also were seen. Dysregulated immune activation was partially corrected by this regimen; however, the perturbed expression of T cell receptor V regions in the CD4 and CD8 T lymphocyte populations was not significantly affected. Ongoing studies will ascertain if longer durations of virus suppression will permit more complete immune restoration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/515591

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 425

Metadata

Authors
Lederman, M. M., Connick, E., Landay, A., Kuritzkes, D. R., Spritzler, J., St. Clair, M., Kotzin, B. L., Fox, L., Heath Chiozzi, M., Leonard, J. M., Rousseau, F., Wade, M., Roe, J. D., Martinez, A., & Kessler, H.
Venue
Journal of Infectious Diseases
Published
1998-07-01
Volume
178
Issue
1
Pages
70-79
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2121956497
Cited by
425
References
32
FWCI
13.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315. https://app.cochat.ai/papers/10.1086/515591
The paper
Lederman, M. M., Connick, E., Landay, A., Kuritzkes, D. R., Spritzler, J., St. Clair, M., Kotzin, B. L., Fox, L., Heath Chiozzi, M., Leonard, J. M., Rousseau, F., Wade, M., Roe, J. D., Martinez, A., & Kessler, H. (1998). Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315. Journal of Infectious Diseases. https://doi.org/10.1086/515591

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.